TY  - JOUR
AU  - de Los Rios, Constanza Ciriza
AU  - Falcón, Blanca Serrano
AU  - Arguelles-Arias, Federico
AU  - Pérez, Esperanza
AU  - Teruel, Carlos
AU  - Geijo, Fernando
AU  - Rey, Enrique
PY  - 2021
DO  - 10.1177/17562848211020570
SN  - 1756-283X
UR  - https://hdl.handle.net/10668/25737
T2  - Therapeutic advances in gastroenterology
AB  - Irritable bowel syndrome with diarrhoea (IBS-D) is a frequent problem associated with a significant socioeconomic implication. Increased gut permeability is an important pathophysiological mechanism. A medical device containing xyloglucan (XG), pea...
LA  - en
KW  - diarrhoea
KW  - gut permeability
KW  - irritable bowel syndrome
KW  - mucoprotectants
KW  - xylo-oligosaccharides
KW  - xyloglucan
TI  - Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome.
TY  - research article
VL  - 14
ER  -